Intelligence Platform

Patents

Browse 206 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9352032

Live attenuated antigenically marked classical swine fever vaccine

The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9278124

Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and co

HALOZYME, INC. · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9180179

Development of a marker foot and mouth disease virus vaccine candidate that is attenuated

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9176122

Biomarkers for predicting response to immunosuppressive therapy

United States Department of Veteran Affairs · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9151762

Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9140687

Renal cell carcinoma biomarkers

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9138453

Nutrient combinations for affecting an aging process

BioMarker Pharmaceuticals, Inc. · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9125923

Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsivenes

The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9103826

Methods and biomarkers for the detection of dengue hemorrhagic fever

The Board of Regents of the University of Texas System · Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9090933

Cancer screening by detection of ultrastructural and molecular markers

Northwestern University · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9063153

Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9040241

Genetic markers of mental illness

SureGene LLC · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987216

Polysulfated glycosides and salts thereof

Teva Hungary Pharmaceutical Marketing Private Limited Company · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8932846

Unmarked recombinant intracellular pathogen immunogenic compositions expressing high level

The Regents of the University of California · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8900880

Viral citrullinated peptides and uses thereof

Toscana Biomarkers S.R.L. · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883948

Methods for extensive dark curing based on visible-light initiated, controlled radical pol

The Regents of the University of Colorado · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877797

Methods for treating Parkinson's disease using pro-neurogenic compounds

The Board of Regents of the University of Texas System · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846006

MRI markers, delivery and extraction systems, and methods of manufacture and use thereof

The Board of Regents of the University of Texas System · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8790869

Renal cell carcinoma biomarkers

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785414

Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögre

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765141

Development of a marker foot and mouth disease virus vaccine candidate that is attenuated

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8759302

Methods of treating a subject afflicted with an autoimmune disease using predictive biomar

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8748114

ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphom

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8735075

Cancer screening by detection of ultrastructural and molecular markers

Northwestern University · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted